✦ LIBER ✦

Association Between Plasma Concentrations of Certolizumab Pegol and Endoscopic Outcomes of Patients With Crohn's Disease

✍ Scribed by Colombel, Jean–Frédéric; Sandborn, William J.; Allez, Matthieu; Dupas, Jean–Louis; Dewit, Olivier; D'Haens, Geert; Bouhnik, Yoram; Parker, Gerald; Pierre–Louis, Bosny; Hébuterne, Xavier

Book ID: 122262725
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 848 KB
Volume: 12
Category: Article
ISSN: 1542-3565
DOI: 10.1016/j.cgh.2013.10.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is Weight-Based Dosing of Adalimumab or

Is Weight-Based Dosing of Adalimumab or Certolizumab Pegol Associated With Higher Efficacy in Patients With Crohn's Disease (CD)?

✍ Wojciech Blonski; Mark T. Osterman; Colleen M. Brensinger; Anna M. Buchner; Gary 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 220 KB

S1045 Endoscopic Mucosal Improvement in

S1045 Endoscopic Mucosal Improvement in Patients With Active Crohn's Disease Treated With Certolizumab Pegol: Week 10 and 54 Results of the Music Trial

✍ Jean-Frederic Colombel; Marc Lemann; Yoram Bouhnik; Olivier Dewit; Jean-Louis Du 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 91 KB

S1065 Predictors of Endoscopic Response

S1065 Predictors of Endoscopic Response and Remission in Patients with Active Crohn's Disease Treated with Certolizumab Pegol: A Logistic Regression Analysis of the Music Data

✍ Jean-Frederic Colombel; Marc Lemann; Matthieu Allez; Krassimir Mitchev; Corinne 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 100 KB

P.1.125: CERTOLIZUMAB PEGOL IN PATIENTS

P.1.125: CERTOLIZUMAB PEGOL IN PATIENTS WITH CROHN'S DISEASE: A LONG TERM UPDATE OF COMPASSIONATE USE

✍ F. Mocciaro; S. Renna; A. Orlando; M. Olivo; E. Sinagra; M. Cottone 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Crohn's Disease Patients With Persistent

Crohn's Disease Patients With Persistently Elevated CRP Plasma Concentration Have Higher Rates of Remission With Certolizumab Pegol 400 mg Every 2 Weeks vs. Every 4 Weeks

✍ Sandborn, William J. ;Vermeire, Severine ;Ernault, Etienne ;Lichtenstein, Gary R 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 300 KB

Randomised clinical trial: improvement i

Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn’s disease with prior loss of response to infliximab

✍ B. G. Feagan; W. J. Sandborn; D. C. Wolf; G. Coteur; O. Purcaru; Y. Brabant; P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB